Clinical Trial Update: A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating sintilimab plus lenvatinib as adjuvant therapy after surgical resection in hepatocellular carcinoma with portal vein tumor thr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Tongji Hospital | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING